深度报告系列培训：昆药集团-

Summary of the Conference Call Company and Industry Involved - The conference call pertains to Dongwu Pharmaceutical, specifically focusing on the Chinese medicine sector and the performance of Kunming Pharmaceutical [1] Core Points and Arguments - The analyst, Li Qian, emphasizes the anticipation surrounding Kunming Pharmaceutical's performance following its integration into China Resources [1] Other Important but Possibly Overlooked Content - The call is part of a series of in-depth reports on Dongwu Pharmaceutical, indicating a structured approach to analyzing the company's developments and market position [1]